8 Apr 2020
Webinar Recording: Ensuring Continuity in Rare Disease Clinical Trials During the COVID-19 Crisis

In this webinar, Ergomed’s experts share their insights on how they have adapted and are continuing to provide reliable and uninterrupted services for their clients, keeping the patient’s safety and well-being as the central focus


Topics include:

  • Ensuring the oversight of ongoing trials in line with regulatory guidance
  • Starting up new trials during the pandemic
  • Practical and logistical issues and mitigations



  • Alex Artyomenko MD, Head of Rare Disease and RWE Research
  • Christa van Kan, Strategic Director Rare Diseases
  • Sally Amanuel MBA, Head of Regulatory and Clinical Delivery


Please click HERE to see the webinar.